BioCentury | May 27, 2013
Finance

Demand disequilibrium

...target) Mar-12 Cancer Research Technology; European Investment Fund CRT Pioneer Fund U.K. $79 (target) Jun-12 Vanadis Capital...
BioCentury | Jun 11, 2012
Financial News

Vanadis Capital AB financial update

...Peborgh, the former CSO of Novartis Scandinavia at Novartis AG (NYSE: NVS; SIX:NOVN, Basel, Switzerland). Vanadis Capital...
BioCentury | Jun 11, 2012
Finance

VC + CRO

...VC + CRO Swedish life sciences venture capital firm Vanadis Capital is raising its first fund and...
BioCentury | Jun 6, 2012
Financial News

Scandinavian fund seeking $48.2M

Vanadis Capital is seeking to close its first fund in March 2013 at SEK350 million ($48.2 million). The fund will invest up to SEK75 million ($10.3 million) in up to 10 biotech, medtech, diagnostic or...
Items per page:
1 - 4 of 4
BioCentury | May 27, 2013
Finance

Demand disequilibrium

...target) Mar-12 Cancer Research Technology; European Investment Fund CRT Pioneer Fund U.K. $79 (target) Jun-12 Vanadis Capital...
BioCentury | Jun 11, 2012
Financial News

Vanadis Capital AB financial update

...Peborgh, the former CSO of Novartis Scandinavia at Novartis AG (NYSE: NVS; SIX:NOVN, Basel, Switzerland). Vanadis Capital...
BioCentury | Jun 11, 2012
Finance

VC + CRO

...VC + CRO Swedish life sciences venture capital firm Vanadis Capital is raising its first fund and...
BioCentury | Jun 6, 2012
Financial News

Scandinavian fund seeking $48.2M

Vanadis Capital is seeking to close its first fund in March 2013 at SEK350 million ($48.2 million). The fund will invest up to SEK75 million ($10.3 million) in up to 10 biotech, medtech, diagnostic or...
Items per page:
1 - 4 of 4